The DOI matches its Crossref record; 143 of the 145 references it cites were found in a registry or an index.
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
Open accessAbstract
OBJECTIVE: Our objective was to develop clinical practice guidelines for the diagnosis and treatment of patients with primary aldosteronism. PARTICIPANTS: The Task Force comprised a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society, six additional experts, one methodologist, and a medical writer. The Task Force received no corporate funding or remuneration. EVIDENCE: Systematic reviews of available evidence were used to formulate the key treatment and prevention recommendations. We used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) group criteria to describe both the quality of evidence and the strength of recommendations. We used "recommend" for strong recommendations and "suggest" for weak recommendations. CONSENSUS PROCESS: Consensus was guided by systematic reviews of evidence and discussions during one group meeting, several conference calls, and multiple e-mail communications. The drafts prepared by the task force with the help of a medical writer were reviewed successively by The Endocrine Society's CGS, Clinical Affairs Core Committee (CACC), and Council. The version approved by the CGS and CACC was placed on The Endocrine Society's Web site for comments by members. At each stage of review, the Task Force received written comments and incorporated needed changes. CONCLUSIONS: We recommend case detection of primary aldosteronism be sought in higher risk groups of hypertensive patients and those with hypokalemia by determining the aldosterone-renin ratio under standard conditions and that the condition be confirmed/excluded by one of four commonly used confirmatory tests. We recommend that all patients with primary aldosteronism undergo adrenal computed tomography as the initial study in subtype testing and to exclude adrenocortical carcinoma. We recommend the presence of a unilateral form of primary aldosteronism should be established/excluded by bilateral adrenal venous sampling by an experienced radiologist and, where present, optimally treated by laparoscopic adrenalectomy. We recommend that patients with bilateral adrenal hyperplasia, or those unsuitable for surgery, optimally be treated medically by mineralocorticoid receptor antagonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mineralocorticoid excess can be caused by either bilateral hyperplasia or ACA, and these lesions are usually small (<2 cm) (115).”
From Adrenocortical carcinoma (2014) · cites this paper as [115]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X. J., Plouin, P., Blacher, J., Safar, M. E., & Mourad, J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,541
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467
Self-citationLifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M. (1992) · Nature · doi:10.1038/355262a0 · Cited by 1,158
The Incidentally Discovered Adrenal Mass
Young, W. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp065470 · Cited by 1,090
Self-citationMulatero (2004) · doi:10.1210/jc.2003-031337 · Cited by 961
Self-citationA Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 907
Self-citationIncidentally Discovered Adrenal Masses*
Kloos, R. T., Gross, M. D., Francis, I. R., KOROBKIN, M. T., & Shapiro, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-460 · Cited by 869
Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension
Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., Thakkar, R. B., & Weissmann, P. (2002) · Hypertension · doi:10.1161/01.hyp.0000040261.30455.b6 · Cited by 763
Flagged first, then by citations
2 of the 145 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Ganguly, 1976, Spironolactone therapy in primary aldosteronism: diagnostic and therapeutic implications, In: Sambhi MP, ed. Systemic effects of antihypertensive agents. New York: Stratton;, 383
Cited by
Sorted by citations
Items 701–800 of 1,000
Diagnosis of Glucocorticoid-Remediable Aldosteronism in Hypertensive Children
Kamrath, C., Maser‐Gluth, C., Haag, C., & Schulze, E. (2011) · Hormone Research in Paediatrics · doi:10.1159/000326524 · Cited by 16
Adrenal Venous Sampling: Where Is the Aldosterone Disappearing to?
Solař, M., Ceral, J., Krajina, A., Ballon, M., Malířová, E., Broďák, M., & Cap, J. (2009) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-009-9722-4 · Cited by 16
Prevalence of Primary Aldosteronism in Hypertensive Subjects with Hyperglycemia
Li, N., Wang, M., Wang, H., Zhang, D., Wang, X., Zu, F.-Y., Chang, G., & Zhou, K. (2012) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2012.712175 · Cited by 16
Catena, C., Colussi, G., & Sechi, L. A. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0899 · Cited by 17
Hyperaldosteronism: Screening and Diagnostic Tests
Sabbadin, C., & Fallo, F. (2016) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-016-0136-5 · Cited by 16
An Interventionist’s Guide to Endocrine Consultations
Monroe, E. J., Carney, B. W., Ingraham, C. R., Johnson, G. E., & Valji, K. (2017) · Radiographics · doi:10.1148/rg.2017160102 · Cited by 16
The blood pressure-lowering effect of renal denervation is inversely related to kidney function
Vink, E. E., Verloop, W. L., Bost, R. B. C., Voskuil, M., Spiering, W., Vonken, E.-J. P. A., Bots, M. L., & Blankestijn, P. J. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000282 · Cited by 15
Liu, X., Hao, S., Bian, J., Lou, Y., Zhang, H., Wu, H., Cai, J., & Ma, W. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae094 · Cited by 15
Steichen, O., Blanchard, A., & Plouin, P. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02401.x · Cited by 16
Overview of the genetic determinants of primary aldosteronism
Al‐Salameh, A., Cohen, R., & Desailloud, R. (2014) · The Application of Clinical Genetics · doi:10.2147/tacg.s45620 · Cited by 15
Prise en charge actuelle de l’hypertension artérielle
Steichen, O., & Plouin, P. (2013) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2013.06.013 · Cited by 16
Ultimately we are in furious agreement
Funder, J. W. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e328356c5be · Cited by 15
Self-citationVink, E. E., Boer, A., Verloop, W. L., Spiering, W., Voskuil, M., Vonken, E.-J. P. A., Hoogduin, J. M., Leiner, T., Bots, M. L., & Blankestijn, P. J. (2015) · European Radiology · doi:10.1007/s00330-014-3583-1 · Cited by 15
Secondary Hypertension, Issues in Diagnosis and Treatment
Pullalarevu, R., Akbar, G., & Teehan, G. S. (2014) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2014.08.001 · Cited by 15
Primary aldosteronism: from bench to bedside
Sukor, N. (2011) · Endocrine · doi:10.1007/s12020-011-9553-3 · Cited by 15
Primary Aldosteronism: what consensus for the diagnosis
Cicala, M.-V., & Mantero, F. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.10.007 · Cited by 15
Self-citationHypokalemic myopathy in primary aldosteronism: A case report
Wu, C.-F., Xin, J., Xin, M., Zou, H., Jing, L., Zhu, C., & Lei, W. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3864 · Cited by 15
Obesity and the diagnostic accuracy for primary aldosteronism
Tirosh, A., Hannah‐Shmouni, F., Lyssikatos, C., Belyavskaya, E., Zilbermint, M. F., Abraham, S. B., Lodish, M. B., & Stratakis, C. A. (2017) · Journal of Clinical Hypertension · doi:10.1111/jch.13041 · Cited by 15
Who should be screened for primary aldosteronism? A comprehensive review of current evidence
Huang, W., Lin, Y., Wu, V., Chen, C., Siddique, S., Chia, Y. C., Tay, J. C., Guruprasad, S., Cheng, H., & Kario, K. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14558 · Cited by 16
Mihailidou, A. S. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0256-9 · Cited by 15
Vitamin D Receptor, an Important Transcription Factor Associated with Aldosterone-Producing Adenoma
Bi, C., Li, B., Du, L., Wang, L., Zhang, Y., Cheng, Z., & Zhai, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082309 · Cited by 15
Raman, S. P., Lessne, M. L., Kawamoto, S., Chen, Y., Salvatori, R., Prescott, J. D., & Fishman, E. K. (2015) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000000208 · Cited by 15
Left Heart Morphology and Function in Primary Aldosteronism
Milan, A., Magnino, C., Fabbri, A., Chiarlo, M., Bruno, G., Losano, I., & Veglio, F. (2012) · High Blood Pressure & Cardiovascular Prevention · doi:10.2165/11593690-000000000-00000 · Cited by 15
Lucatello, B. G., Benso, A. S., Tabaro, I., Capello, E. C., Parasiliti‐Caprino, M., Marafetti, L., Rossato, D., Oleandri, S. E., Ghigo, E., & Maccario, M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0912 · Cited by 15
Evaluation of Endocrine Function
Guber, H. A., & Farag, A. F. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0974-2.00024-5 · Cited by 15
Okamoto, R., Taniguchi, M., Onishi, Y., Kumagai, N., Uraki, J., Fujimoto, N., Fujii, E., Yano, Y., Ogura, T., & Ito, M. (2018) · Hypertension Research · doi:10.1038/s41440-018-0126-1 · Cited by 15
Karashima, S., Yoneda, T., Kometani, M., Ohe, M., Mori, S., Sawamura, T., Furukawa, K., Yamagishi, M., & Takeda, Y. (2016) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2016.1151526 · Cited by 15
Pathophysiology, Diagnosis, and Treatment of Mineralocorticoid Disorders
Magill, S. B. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130042 · Cited by 15
Li, T., Ma, Y., Zhang, Y., Liu, Y., Fu, T., Zhang, R., Kang, K., Yang, Y., Wang, L., Jiang, Y., et al. (2019) · International Journal of Hypertension · doi:10.1155/2019/2195796 · Cited by 14
Endovascular Renal Artery Denervation: Why, When, and How?
Sapoval, M. R., Azizi, M., Bobrie, G., Cholley, B., Pagny, J.-Y., & Plouin, P. (2012) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-011-0306-8 · Cited by 14
Stowasser, M. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.182469 · Cited by 14
Self-citationGenetic disorders in primary aldosteronism—familial and somatic
Funder, J. W. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.020 · Cited by 14
Self-citationMolinnus, D., Sorich, M., Bartz, A., Siegert, P., Willenberg, H. S., Lisdat, F., Poghossian, A., Keusgen, M., & Schöning, M. J. (2016) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2016.06.064 · Cited by 14
Cardiac Dysfunction in Association with Increased Inflammatory Markers in Primary Aldosteronism
Lim, J. S., Park, S., Park, S. I., Oh, Y. T., Choi, E. H., Kim, J., & Rhee, Y. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.4.567 · Cited by 14
Varano, M., Iacono, P., Tedeschi, M., Letizia, C., Curione, M., Savoriti, C., Baiocco, E., Zinnamosca, L., Marinelli, C., Boccassini, B., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02622-2 · Cited by 14
Swearingen, A. J., Kahramangil, B., Monteiro, R., Krishnamurthy, V. D., Jin, J., Shin, J., SIPERSTEIN, A. E., & Berber, E. (2017) · Surgery · doi:10.1016/j.surg.2017.10.045 · Cited by 14
Zein, R. M. E., Soria, A. H., Dzib, J. F. G., Rickard, A. J., Fernandes-Rosa, F. L., Samson-Couterie, B., Giscos-Douriez, I., Rocha, A., Poglitsch, M., Gómez-Sánchez, C. E., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50988-2 · Cited by 14
Zhang, S.-L., Gao, J., Guo, Y., Feng, Q., Tang, J., Yan, L., Wang, J., Cheng, H., & Liu, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.547356 · Cited by 14
Zhang, C., Wu, L., Jiang, L., Su, T., Zhou, W., Zhong, X., Xie, J., Sun, F., Zhu, Y., Jiang, Y., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.01.007 · Cited by 14
Clinical and biochemical predictors and predictive model of primary aldosteronism
Manosroi, W., Tacharearnmuang, N., & Atthakomol, P. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272049 · Cited by 14
Prevalence of Primary Aldosteronism in Newly Diagnosed Hypertensive Patients in Primary Care
Asbach, E., Kellnar, A., Bekeran, M., Schelling, J., Bidlingmaier, M., & Reincke, M. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1938-4242 · Cited by 14
Assessment and management of resistant hypertension
Padwal, R. S., Rabkin, S. W., & Khan, N. A. (2014) · Canadian Medical Association Journal · doi:10.1503/cmaj.130764 · Cited by 14
Prevalence of Malignancies in Patients With Primary Aldosteronism
Lang, K., Weber, K., Quinkler, M. O., Dietz, A., Wallaschofski, H., Hannemann, A., Friedrichs, N., Rump, L. C., Heinze, B., Fuss, C. T., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3405 · Cited by 14
Grotevendt, A., Wallaschofski, H., Reincke, M., Adolf, C., Quinkler, M. O., Nauck, M. A., Hoffmann, W. U., Rettig, R., & Hannemann, A. (2017) · Endocrine · doi:10.1007/s12020-017-1348-8 · Cited by 14
Daimon, M., KAMBA, A., Murakami, H., Mizushiri, S., Osonoi, S., Matsuki, K., Sato, E., Tanabe, J., Takayasu, S., Matsuhashi, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10815-y · Cited by 14
on behalf of WAVES-J Study Group, Fujii, Y., Umakoshi, H., Wada, N., Ichijo, T., Kamemura, K., Matsuda, Y., Kai, T., Fukuoka, T., Sakamoto, R., et al. (2017) · Journal of Human Hypertension · doi:10.1038/s41371-017-0015-0 · Cited by 14
Pharmacological and analytical interference in hormone assays for diagnosis of adrenal incidentaloma
Lopez, A.-G., Fraissinet, F., Lefèbvre, H., Brunel, V., & Ziegler, F. (2019) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.11.006 · Cited by 14
A case of primary aldosteronism revealed after renal transplantation
Hoorn, E. J., Hesselink, D. A., Kho, M. M. L., Roodnat, J. I., Weimar, W. W., van Saase, J. L., van den Meiracker, A. H., & Zietse, R. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.158 · Cited by 14
Is it Possible to Extirpate Cardiovascular Events in Primary Aldosteronism after Surgical Treatment
Nishikawa, T., Matsuzawa, Y., Saito, J., & Omura, M. (2010) · Japanese Clinical Medicine · doi:10.4137/jcm.s6316 · Cited by 14
Denimal, D., & Duvillard, L. (2016) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563216645364 · Cited by 14
Grübler, M. R., Kienreich, K., Gaksch, M., Verheyen, N., Hartaigh, B. Ó., Fahrleitner-Pammer, A., März, W., Schmid, J., Oberreither, E.-M., Wetzel, J., et al. (2016) · Medicine · doi:10.1097/md.0000000000002794 · Cited by 13
Diagnóstico del hiperaldosteronismo primario
Castro, M. A., & Ramírez, P. A. P. (2021) · Medicina Clínica · doi:10.1016/j.medcli.2021.10.012 · Cited by 13
Target organ damage in untreated hypertensive patients with primary aldosteronism
Li, S., Huang, J., Zhu, C., Ng, M., Lin, Q., Wu, M., Liu, M., Wang, R., Cao, G., Chen, C., et al. (2024) · Journal of Clinical Hypertension · doi:10.1111/jch.14794 · Cited by 13
Coaxial Guide Wire Placement in the Right Adrenal Vein for Repeated Adrenal Venous Samplings
Kaitoukov, Y., Soulez, G., Oliva, V. L., Giroux, M.-F., Bourdeau, I., Lacroix, A., Gilbert, P., & Thérasse, É. (2013) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-013-0794-9 · Cited by 13
The Renaissance of Primary Aldosteronism: What Has it Taught Us?
Stowasser, M., & Gordon, R. D. (2013) · Heart Lung and Circulation · doi:10.1016/j.hlc.2013.01.006 · Cited by 14
Self-citationHenderson, M. C., Dhaliwal, G., Jones, S. R., Culbertson, C., & Bowen, J. L. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-009-1187-2 · Cited by 13
Reliability of a Bayesian network to predict an elevated aldosterone-to-renin ratio
Ducher, M., Mounier‐Véhier, C., Lantelme, P., Vaisse, B., Baguet, J.-P., & Fauvel, J. (2015) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2014.09.011 · Cited by 13
Pizzolo, F., Zorzi, F., Chiecchi, L., Consoli, L., Aprili, I., Guarini, P., Castagna, A., Salvagno, G. L., Pavan, C., & Olivieri, O. (2013) · Endocrine · doi:10.1007/s12020-013-0028-6 · Cited by 13
Myśliwiec, J., & Górska, M. (2012) · PubMed · Cited by 13
Diagnosis and Management of Primary Aldosteronism
(2011) · The Nurse Practitioner · doi:10.1097/01.npr.0000396310.36814.a6 · Cited by 13
Komada, H., Hirota, Y., So, A., Nakamura, T., Okuno, Y., Fukuoka, H., Iguchi, G., Takahashi, Y., Sakaguchi, K., & Ogawa, W. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.10.002 · Cited by 15
Diagnostic and therapeutic approach to hypernatremia
Ilardi, A. (2022) · Diagnosis · doi:10.1515/dx-2022-0034 · Cited by 13
Rebelo, J. F. D., Costa, J. M., Junqueira, F. D., Fonseca, A. D. O., de Almeida, A. B. A. B. S., Moraes, A. B., & Neto, L. V. (2022) · Clinical Endocrinology · doi:10.1111/cen.14861 · Cited by 13
Karamouzis, I., Berardelli, R., Marinazzo, E., D’Angelo, V., Zinnà, D., Minetto, M. A., Zichi, C., Fussotto, B., Giordano, R., Ghigo, E., et al. (2012) · Pituitary · doi:10.1007/s11102-012-0435-3 · Cited by 13
Pimenta, E., Gordon, R. D., Ahmed, A. H., Cowley, D., Robson, D., Kogovsek, C., & Stowasser, M. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.102 · Cited by 13
Self-citationIs Adrenal Venous Sampling Mandatory before Surgical Decision in Case of Primary Hyperaldosteronism?
Pirvu, A., Naem, N., Baguet, J.-P., Thony, F., Chabre, O., & Chaffanjon, P. C. (2014) · World Journal of Surgery · doi:10.1007/s00268-014-2461-y · Cited by 13
Blood Pressure Control 1 Year After Referral to a Hypertension Specialist
Denker, M. G., Haddad, D. B., Townsend, R. R., & Cohen, D. L. (2013) · Journal of Clinical Hypertension · doi:10.1111/jch.12146 · Cited by 14
Kline, G. A. (2015) · Clinical Endocrinology · doi:10.1111/cen.12798 · Cited by 13
Screening for primary aldosteronism using the newly developed IDS-iSYS® automated assay system
O’Shea, P. M., Griffin, T. P., Browne, G. A., Gallagher, N., Brady, J. J., Dennedy, M. C., Bell, M., Wall, D., & Fitzgibbon, M. C. (2016) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2016.11.002 · Cited by 13
How to Escape from Primary Aldosteronism? News and Views on an Adrenal Disorder of Salt Retention
Willenberg, H. S. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-100767 · Cited by 13
Prevalence of primary aldosteronism among patients with type 2 diabetes
Tancredi, M., Johannsson, G., Eliasson, B., Eggertsen, R., Lindblad, U., Dahlqvist, S., Imberg, H., & Lind, M. (2017) · Clinical Endocrinology · doi:10.1111/cen.13370 · Cited by 13
Decoding resistant hypertension signalling pathways
Parreira, R. C., Lacerda, L. H. G., Vasconcellos, R., Lima, S. S., Santos, A. K., Fontana, V., Sandrim, V. C., & Resende, R. R. (2017) · Clinical Science · doi:10.1042/cs20171398 · Cited by 13
Cardiac magnetic resonance imaging of myocardial mass and fibrosis in primary aldosteronism
Grytaas, M. A., Sellevåg, K., Thordarson, H. B., Husebye, E. S., Løvås, K., & Larsen, T. H. (2018) · Endocrine Connections · doi:10.1530/ec-18-0039 · Cited by 13
Laparoscopic Surgery’s 100 Most Influential Manuscripts: A Bibliometric Analysis
Mellor, K., Powell, A. G. M. T., & Lewis, W. G. (2018) · Surgical Laparoscopy Endoscopy & Percutaneous Techniques · doi:10.1097/sle.0000000000000507 · Cited by 14
JPAS Study Group, Fujii, Y., Takeda, Y., Kurihara, I., Itoh, H., Katabami, T., Ichijo, T., Wada, N., Shibayama, Y., Yoshimoto, T., et al. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0229-4 · Cited by 13
Li, K., Duan, X., Yang, X., Huang, J., & Wu, T. (2021) · Updates in Surgery · doi:10.1007/s13304-021-01116-1 · Cited by 13
Syndromes of Mineralocorticoid Excess
Melcescu, E., & Koch, C. A. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-548-4_2 · Cited by 13
Incidental Adrenal Enlargement: An Overview from a Retrospective Study in a Chinese Population
Li, L., Gu, W., Dou, J., Yang, G., Lv, Z., Mu, Y., & Lu, J. (2015) · International Journal of Endocrinology · doi:10.1155/2015/192874 · Cited by 13
Diagnostics of primary aldosteronism: is obligatory use of confirmatory tests justified?
Myśliwiec, J., Żukowski, Ł., Grodzka, A., Pilaszewicz‐Puza, A., Drągowski, S., & Górska, M. (2012) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320312438791 · Cited by 13
Huang, Y., Ting, P. Y., Yao, T. M., Homma, T., Brooks, D. L. P., Rangel, I. K., Adler, G. K., Romero, J. R., Williams, J. S., Pojoga, L. H., et al. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0247 · Cited by 13
Primary Aldosteronism—One Picture Is Not Worth a Thousand Words
Young, W. F. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-5-200909010-00013 · Cited by 13
Self-citationEngler, L., Adolf, C., Heinrich, D. A., Brem, A., Riester, A., Franke, A., Beuschlein, F., Reincke, M., Steiger, A., & Kunzel, H. E. (2019) · Endocrine Connections · doi:10.1530/ec-19-0043 · Cited by 12
Chen, P., Li, P.-Y., Liu, K., Wu, V., Lin, Y., Chueh, S., Chen, C., & Chang, C. (2023) · Academic Radiology · doi:10.1016/j.acra.2023.10.015 · Cited by 12
Aldosterone Effect on Cardiac Structure and Function
Al‐Hashedi, E. M., & Abdu, F. A. (2024) · Current Cardiology Reviews · doi:10.2174/011573403x281390240219063817 · Cited by 12
Jiang, Y., Zhou, L., Zhang, C., Su, T., Jiang, L., Zhou, W., Zhong, X., Wu, L., & Wang, W. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1369582 · Cited by 12
Słapa, R. Z., Kasperlik-Zaluska, A. A., Migda, B., Otto, M., & Jakubowski, W. S. (2015) · European Journal of Radiology · doi:10.1016/j.ejrad.2015.05.006 · Cited by 12
The possibility of resistant hypertension during the treatment of hypertensive patients
Nishikawa, T., Omura, M., Saito, J., & Matsuzawa, Y. (2013) · Hypertension Research · doi:10.1038/hr.2013.107 · Cited by 12
Kashiwagi, Y., Mizuno, Y., Harada, E., Shono, M., Morita, S., Yasue, H., Yoshimura, M., & Yano, M. (2013) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31827ad893 · Cited by 12
The E3 ubiquitin ligase Siah1 regulates adrenal gland organization and aldosterone secretion
Scortegagna, M., Berthon, A. S., Settas, N., Giannakou, A., Garcia, G., Li, J., James, B. P., Liddington, R., Vilches-Moure, J. G., Stratakis, C. A., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.97128 · Cited by 12
Baba, Y., Nakajo, M., & Hayashi, S. (2012) · Endocrine · doi:10.1007/s12020-012-9792-y · Cited by 12
Treatment of primary aldosteronism: Where are we now?
Karagiannis, A. I. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9159-3 · Cited by 12
Kline, G. A., Dias, V. C., So, B., Harvey, A. M., & Pasieka, J. L. (2014) · World Journal of Surgery · doi:10.1007/s00268-014-2694-9 · Cited by 12
Kline, G. A., Pasieka, J. L., Harvey, A. M., So, B., & Dias, V. C. (2013) · Journal of Human Hypertension · doi:10.1038/jhh.2013.116 · Cited by 12
Secondary Hypertension: The Ways of Management
Rossi, G. P., Seccia, T. M., & Pessina, A. C. (2010) · Current Vascular Pharmacology · doi:10.2174/157016110793563843 · Cited by 12
Glinicki, P., Jeske, W., Gietka‐Czernel, M., Papierska, L., Kruszyńska, A., Slowinska-Srzednicka, J., & Zgliczyński, W. (2013) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320313494434 · Cited by 12
Diagnostic criteria for adrenal venous sampling
Steichen, O., & Amar, L. (2016) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000250 · Cited by 12
Ruling out secondary causes of hypertension
Ott, C., Schneider, M. P., & Schmieder, R. E. (2013) · EuroIntervention · doi:10.4244/eijv9sra5 · Cited by 12
Prediction of Adrenal Adenomas With Hypercortisolism by Using Adrenal Computed Tomography
Park, S. Y., Oh, Y. T., Jung, D. C., & Rhee, Y. (2015) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000000269 · Cited by 12
Akkuş, G., Evran, M., Sert, M., Ok, F., & Tetıker, T. (2017) · Health Science Reports · doi:10.1002/hsr2.22 · Cited by 13
A short review of primary aldosteronism in a question and answer fashion
Farrugia, F., Zavras, N., Martikos, G., Tzanetis, P., Charalampopoulos, A. A., Misiakos, E. P., Sotiropoulos, D., & Koliakos, N. N. (2018) · Endocrine Regulations · doi:10.2478/enr-2018-0005 · Cited by 12
Metadata
- Authors
- Funder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M.
- Affiliations
- Prince Henry’s Institute of Medical Research (J.W.F.), Clayton VIC 3168, Australia
- University of Virginia Health System (US)
- Pontificia Universidad Católica de Chile (CL)
- G.V. (Sonny) Montgomery VA Medical Center (C.E.G.-S.), Jackson, Mississippi 39216
- University of Padua (IT)
- The University of Queensland (AU)
- Mayo Clinic (US)
- Mayo Clinic (W.F.Y., V.M.M.), Rochester, Minnesota 55902
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-09-01
- Volume
- 93
- Issue
- 9
- Pages
- 3266-3281
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2156903075
- Cited by
- 1,554
- References
- 145
- Citations by year
- 2026: 19 · 2025: 29 · 2024: 34 · 2023: 42 · 2022: 42 · 2021: 51 · 2020: 50 · 2019: 56 · 2018: 70 · 2017: 84 · 2016: 158 · 2015: 182 · 2014: 135 · 2013: 127 · 2012: 169
- FWCI
- 72.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Americanae (AECID Library) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Keywords
- primary aldosteronism, case finding, aldosterone-renin ratio, confirmatory testing, adrenal computed tomography, unilateral primary aldosteronism, laparoscopic adrenalectomy, bilateral adrenal hyperplasia, mineralocorticoid receptor antagonists, hypertension, hypokalemia
- MeSH terms
- Eplerenone, Mineralocorticoid Receptor Antagonists, Algorithms, Catheterization, Combined Modality Therapy, Cosyntropin, Diagnostic Techniques, Endocrine, Humans, Hyperaldosteronism, Spironolactone, Reproducibility of Results, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
